Sensory impairment and beta-amyloid deposition in the Baltimore longitudinal study of aging

Alzheimers Dement (Amst). 2023 Apr 30;15(2):e12407. doi: 10.1002/dad2.12407. eCollection 2023 Apr-Jun.

Abstract

Introduction: Beta-amyloid (Aβ) plaque deposition is a biomarker of preclinical Alzheimer's disease (AD). Impairments in sensory function are associated with cognitive decline. We sought to investigate the relationship between PET-indicated Aβ deposition and sensory impairment.

Methods: Using data from 174 participants ≥55 years in the Baltimore Longitudinal Study of Aging, we analyzed associations between sensory impairments and Aβ deposition measured by PET and Pittsburgh Compound B (PiB) mean cortical distribution volume ratio (cDVR).

Results: The combinations of hearing and proprioceptive impairment and hearing, vision, and proprioceptive impairment, were positively correlated with cDVR (β = 0.087 and p = 0.036, β = 0.110 and p = 0.018, respectively). In stratified analyses of PiB+ participants, combinations of two, three, and four sensory impairments (all involving proprioception) were associated with higher cDVR.

Discussion: Our findings suggest a relationship between multi-sensory impairment (notably proprioceptive impairment) and Aβ deposition, which could reflect sensory impairment as an indicator or potentially a risk factor for Aβ deposition.

Keywords: Alzheimer disease; beta‐amyloid; hearing impairment; positron‐emission tomography; proprioceptive disorders; vestibular deficiency; visual impairment.